Drug approval highlights for 2003.

Abstract

In the past 12 months, the FDA has approved important new pharmaceutical drugs and devices of particular interest to primary health care providers. The drugs include: Oxytrol (for urinary incontinence), Valtrex (for reducing the risk of heterosexual transmission of genital herpes), Femring (for vaginal delivery of hormone therapy), Uroxatral (for benign… (More)

Topics

Cite this paper

@article{Laustsen2004DrugAH, title={Drug approval highlights for 2003.}, author={Gary Laustsen and Lynn Wimett}, journal={The Nurse practitioner}, year={2004}, volume={29 2}, pages={8-15, 19-21; quiz 21-3} }